Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 5.40
+0.02 (0.37%)
At close: Sep 25, 2026
Garofalo Health Care Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 487.02 | 478.83 | 462.18 | 360.98 | 314.76 | 277.87 |
Other Revenue | 6.78 | 6.29 | 5.59 | 5.16 | 5.28 | 5.06 |
| 493.8 | 485.12 | 467.77 | 366.14 | 320.04 | 282.93 | |
Revenue Growth | 4.01% | 3.71% | 27.76% | 14.40% | 13.12% | 35.80% |
Cost of Revenue | 389.26 | 381.23 | 367.94 | 286.15 | 251.39 | 222.42 |
Gross Profit | 104.54 | 103.89 | 99.83 | 79.98 | 68.65 | 60.51 |
Selling, General & Admin | 0.98 | 0.98 | 1.01 | 0.89 | 0.83 | 0.67 |
Other Operating Expenses | 20.98 | 20.57 | 21.29 | 14.47 | 13.74 | 11.74 |
Operating Expenses | 50.26 | 49.46 | 47.63 | 36.8 | 32.93 | 27.93 |
Operating Income | 54.28 | 54.44 | 52.2 | 43.18 | 35.72 | 32.58 |
Interest Expense | -10.97 | -10.84 | -13.92 | -10.29 | -4.2 | -4.21 |
Interest & Investment Income | 0.37 | 0.48 | 1.07 | 0.28 | 0.02 | 0 |
Earnings From Equity Investments | 0.15 | 0.08 | 0.12 | 0.17 | 0.13 | 0.21 |
Other Non Operating Income (Expenses) | -0.83 | -0.91 | -0.71 | -0.46 | -0.24 | -0.25 |
EBT Excluding Unusual Items | 43 | 43.25 | 38.76 | 32.88 | 31.43 | 28.34 |
Gain (Loss) on Sale of Investments | - | - | -0.02 | - | - | - |
Gain (Loss) on Sale of Assets | 0.21 | 0.22 | 0.61 | 0.08 | 0.14 | 0.06 |
Asset Writedown | -3.79 | -1.05 | -0.83 | -1.67 | -0.6 | -0.19 |
Legal Settlements | -9.12 | -5.98 | -5.4 | -2.39 | -3.78 | -2.73 |
Pretax Income | 30.52 | 36.54 | 33.17 | 28.93 | 27.37 | 25.48 |
Income Tax Expense | 11.25 | 12.97 | 11.32 | 8.06 | 5.94 | 6.63 |
Earnings From Continuing Operations | 19.27 | 23.57 | 21.85 | 20.87 | 21.43 | 18.84 |
Minority Interest in Earnings | -0.1 | -0.16 | -0.15 | -0.07 | -0.01 | -0.01 |
Net Income | 19.17 | 23.41 | 21.7 | 20.8 | 21.43 | 18.83 |
Net Income to Common | 19.17 | 23.41 | 21.7 | 20.8 | 21.43 | 18.83 |
Net Income Growth | -13.68% | 7.87% | 4.34% | -2.93% | 13.76% | 59.87% |
Shares Outstanding (Basic) | 89 | 89 | 88 | 89 | 89 | 89 |
Shares Outstanding (Diluted) | 90 | 90 | 90 | 89 | 89 | 89 |
Shares Change | -0.85% | -0.77% | 2.11% | -0.40% | -0.37% | 9.34% |
EPS (Basic) | 0.22 | 0.26 | 0.25 | 0.23 | 0.24 | 0.21 |
EPS (Diluted) | 0.21 | 0.26 | 0.24 | 0.18 | 0.24 | 0.21 |
EPS Growth | -15.72% | 8.33% | 33.33% | -25.00% | 14.29% | 50.00% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 15.28 | 18.12 | 16.7 | 34.57 | 30.04 | 13.12 |
Free Cash Flow Per Share | 0.17 | 0.20 | 0.18 | 0.39 | 0.34 | 0.15 |
Dividend Per Share | 0.093 | 0.093 | 0.086 | - | - | - |
Dividend Growth | 8.14% | 8.14% | - | - | - | - |
Gross Margin | 21.17% | 21.42% | 21.34% | 21.84% | 21.45% | 21.39% |
Operating Margin | 10.99% | 11.22% | 11.16% | 11.79% | 11.16% | 11.52% |
Profit Margin | 3.88% | 4.83% | 4.64% | 5.68% | 6.69% | 6.66% |
Free Cash Flow Margin | 3.09% | 3.74% | 3.57% | 9.44% | 9.38% | 4.64% |
EBITDA | 76.65 | 77.73 | 77.53 | 64.62 | 54.09 | 48.1 |
EBITDA Margin | 15.52% | 16.02% | 16.57% | 17.65% | 16.90% | 17.00% |
D&A For EBITDA | 22.37 | 23.29 | 25.33 | 21.44 | 18.36 | 15.52 |
EBIT | 54.28 | 54.44 | 52.2 | 43.18 | 35.72 | 32.58 |
EBIT Margin | 10.99% | 11.22% | 11.16% | 11.79% | 11.16% | 11.52% |
Effective Tax Rate | 36.86% | 35.50% | 34.13% | 27.85% | 21.69% | 26.04% |
Revenue as Reported | 495.92 | 487.08 | 470.71 | 368.7 | 322.58 | 283.67 |